Resonance Specialties Approves Acquisition of Manufacturing Unit and Reports Q1 Financial Results
Resonance Specialties Limited announced key outcomes from its Board of Directors meeting, including the approval of unaudited financial results for the first quarter ending June 30, 2026, and the proposed purchase of a manufacturing facility. The company also detailed the terms of the acquisition of a unit located in Madhya Pradesh.The board meeting approved the purchase of a manufacturing facility from Kaygee Laboratories Private Limited (KLPL), which is identified as a related party within the promoter group. The transaction for the undertaking, situated at Plot No. 6 in New Industrial Area II, Mandideep, Dist Raisen in Madhya Pradesh, carries a consideration of Rs. 29.98 crores on a slump sale basis.
The acquired assets include the leasehold land (approximately 22,304 sq. mtrs.), industrial buildings (around 5,227 sq. mtrs.), plant and machinery, associated licenses, permits, and employees of the manufacturing unit. The company expects to finalize the agreement in due course and complete the purchase on or before November 30, 2026.
The rationale for the acquisition is to secure an uninterrupted production facility for specialized chemical intermediates and APIs that are currently manufactured at this site. The move aims to enhance operational control and efficiency while eliminating additional costs associated with outsourcing these manufacturing activities, as the unit has been inspected and approved by WHO, Geneva.
Q1 2026 Financial Performance Summary
Resonance Specialties Limited posted its unaudited financial results for the quarter ended June 30, 2026. Key highlights from the performance include:| Metric | Quarter Ended June 30, 2026 (Unaudited) | Quarter Ended June 30, 2025 (Unaudited) |
|---|---|---|
| Total Income | 3,312.19 Lakhs | 2,150.13 Lakhs |
| Profit for the Period (Net) | 574.42 Lakhs | 163.04 Lakhs |
| Earnings Per Equity Share (Basic/Diluted) | 4.98 | 1.41 |
The company reported a revenue from operations of 3,258.41 Lakhs for the current quarter. Total expenses were recorded at 2,547.26 Lakhs, resulting in a profit for the period (net) of 574.42 Lakhs.
Geographical Segment Reporting
The company provided details regarding its geographical segments for the first quarter:| Region | Revenue (April to June, 2026) | Revenue (April to June, 2025) |
|---|---|---|
| India | 932.33 Lakhs | 1,061.93 Lakhs |
| Outside India | 2,326.08 Lakhs | 1,065.49 Lakhs |
The company stated that the manufacturing unit being acquired from Kaygee Laboratories Private Limited is a related party entity, and the transaction has been conducted on an arm's length basis based on a valuation certificate issued by an Independent Registered valuer. The acquisition will not result in any change in the company’s shareholding pattern.
Stock Price Movement
As of 12:15, Resonance Specialties Ltd is climbing higher, trading at ₹154.35 which reflects a 5.00% jump today. The shares have seen significant intraday volatility, having moved between a low of ₹147.20 and the current high of ₹154.35.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.